annual total liabilities:
$7.92B+$262.14M(+3.42%)Summary
- As of today (May 21, 2025), JAZZ annual total liabilities is $7.92 billion, with the most recent change of +$262.14 million (+3.42%) on December 31, 2024.
- During the last 3 years, JAZZ annual total liabilities has fallen by -$414.95 million (-4.98%).
- JAZZ annual total liabilities is now -4.98% below its all-time high of $8.33 billion, reached on December 31, 2021.
Performance
JAZZ Total liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly total liabilities:
$7.36B-$558.71M(-7.06%)Summary
- As of today (May 21, 2025), JAZZ quarterly total liabilities is $7.36 billion, with the most recent change of -$558.71 million (-7.06%) on March 1, 2025.
- Over the past year, JAZZ quarterly total liabilities has dropped by -$270.82 million (-3.55%).
- JAZZ quarterly total liabilities is now -18.96% below its all-time high of $9.08 billion, reached on June 30, 2021.
Performance
JAZZ quarterly total liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Total liabilities Formula
Total Liabilities = Current Liabilities + Long-Term Liabilities
JAZZ Total liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +3.4% | -3.5% |
| 3 y3 years | -5.0% | -9.8% |
| 5 y5 years | +226.1% | +205.8% |
JAZZ Total liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -5.0% | +3.4% | -9.8% | at low |
| 5 y | 5-year | -5.0% | +226.1% | -19.0% | +205.8% |
| alltime | all time | -5.0% | >+9999.0% | -19.0% | >+9999.0% |
JAZZ Total liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2025 | - | $7.36B(-7.1%) |
| Dec 2024 | $7.92B(+3.4%) | $7.92B(-2.1%) |
| Sep 2024 | - | $8.08B(+6.4%) |
| Jun 2024 | - | $7.60B(-0.4%) |
| Mar 2024 | - | $7.63B(-0.3%) |
| Dec 2023 | $7.66B(-1.2%) | $7.66B(-0.8%) |
| Sep 2023 | - | $7.71B(-0.3%) |
| Jun 2023 | - | $7.73B(+0.3%) |
| Mar 2023 | - | $7.71B(-0.5%) |
| Dec 2022 | $7.75B(-7.0%) | $7.75B(+1.4%) |
| Sep 2022 | - | $7.64B(-4.5%) |
| Jun 2022 | - | $8.00B(-2.0%) |
| Mar 2022 | - | $8.16B(-2.1%) |
| Dec 2021 | $8.33B(+189.7%) | $8.33B(-2.4%) |
| Sep 2021 | - | $8.54B(-6.0%) |
| Jun 2021 | - | $9.08B(+206.9%) |
| Mar 2021 | - | $2.96B(+2.9%) |
| Dec 2020 | $2.88B(+18.5%) | $2.88B(-1.3%) |
| Sep 2020 | - | $2.91B(-0.3%) |
| Jun 2020 | - | $2.92B(+21.5%) |
| Mar 2020 | - | $2.41B(-0.9%) |
| Dec 2019 | $2.43B(-0.7%) | $2.43B(-1.8%) |
| Sep 2019 | - | $2.47B(-1.3%) |
| Jun 2019 | - | $2.51B(-1.7%) |
| Mar 2019 | - | $2.55B(+4.2%) |
| Dec 2018 | $2.45B(+1.5%) | $2.45B(-0.5%) |
| Sep 2018 | - | $2.46B(-0.8%) |
| Jun 2018 | - | $2.48B(-0.9%) |
| Mar 2018 | - | $2.50B(+3.7%) |
| Dec 2017 | $2.41B(-17.5%) | $2.41B(-4.7%) |
| Sep 2017 | - | $2.53B(-2.8%) |
| Jun 2017 | - | $2.60B(-8.1%) |
| Mar 2017 | - | $2.83B(-3.1%) |
| Dec 2016 | $2.92B(+68.6%) | $2.92B(-9.1%) |
| Sep 2016 | - | $3.21B(+83.1%) |
| Jun 2016 | - | $1.76B(-8.9%) |
| Mar 2016 | - | $1.93B(+11.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2015 | $1.73B(-11.9%) | $1.73B(-8.8%) |
| Sep 2015 | - | $1.90B(-2.3%) |
| Jun 2015 | - | $1.95B(+0.7%) |
| Mar 2015 | - | $1.93B(-1.8%) |
| Dec 2014 | $1.97B(+108.7%) | $1.97B(-2.0%) |
| Sep 2014 | - | $2.01B(+7.0%) |
| Jun 2014 | - | $1.88B(-2.8%) |
| Mar 2014 | - | $1.93B(+104.7%) |
| Dec 2013 | $942.69M(+11.5%) | $942.69M(+0.1%) |
| Sep 2013 | - | $941.80M(+2.5%) |
| Jun 2013 | - | $918.43M(+8.3%) |
| Mar 2013 | - | $847.79M(+0.3%) |
| Dec 2012 | $845.20M(+1290.5%) | $845.20M(+0.5%) |
| Sep 2012 | - | $840.61M(-3.0%) |
| Jun 2012 | - | $866.49M(+663.2%) |
| Mar 2012 | - | $113.53M(+86.8%) |
| Dec 2011 | $60.78M(-42.2%) | $60.78M(-8.6%) |
| Sep 2011 | - | $66.48M(-27.6%) |
| Jun 2011 | - | $91.81M(-2.4%) |
| Mar 2011 | - | $94.11M(-10.5%) |
| Dec 2010 | $105.18M(-41.6%) | $105.18M(-7.4%) |
| Jun 2010 | - | $113.56M(-35.4%) |
| Mar 2010 | - | $175.70M(-2.5%) |
| Dec 2009 | $180.23M(-14.3%) | $180.23M(-2.4%) |
| Sep 2009 | - | $184.61M(-6.5%) |
| Jun 2009 | - | $197.47M(-2.4%) |
| Mar 2009 | - | $202.23M(-3.9%) |
| Dec 2008 | $210.38M(+37.9%) | $210.38M(-3.5%) |
| Sep 2008 | - | $217.97M(-1.9%) |
| Jun 2008 | - | $222.21M(-1.9%) |
| Mar 2008 | - | $226.58M(+48.5%) |
| Dec 2007 | $152.56M(-61.0%) | $152.56M(+3.7%) |
| Sep 2007 | - | $147.08M(-0.5%) |
| Jun 2007 | - | $147.79M(+21.0%) |
| Mar 2007 | - | $122.09M(-68.8%) |
| Dec 2006 | $390.87M(+38.1%) | $390.87M(+38.1%) |
| Dec 2005 | $283.03M | $283.03M |
FAQ
- What is Jazz Pharmaceuticals annual total liabilities?
- What is the all time high annual total liabilities for Jazz Pharmaceuticals?
- What is Jazz Pharmaceuticals annual total liabilities year-on-year change?
- What is Jazz Pharmaceuticals quarterly total liabilities?
- What is the all time high quarterly total liabilities for Jazz Pharmaceuticals?
- What is Jazz Pharmaceuticals quarterly total liabilities year-on-year change?
What is Jazz Pharmaceuticals annual total liabilities?
The current annual total liabilities of JAZZ is $7.92B
What is the all time high annual total liabilities for Jazz Pharmaceuticals?
Jazz Pharmaceuticals all-time high annual total liabilities is $8.33B
What is Jazz Pharmaceuticals annual total liabilities year-on-year change?
Over the past year, JAZZ annual total liabilities has changed by +$262.14M (+3.42%)
What is Jazz Pharmaceuticals quarterly total liabilities?
The current quarterly total liabilities of JAZZ is $7.36B
What is the all time high quarterly total liabilities for Jazz Pharmaceuticals?
Jazz Pharmaceuticals all-time high quarterly total liabilities is $9.08B
What is Jazz Pharmaceuticals quarterly total liabilities year-on-year change?
Over the past year, JAZZ quarterly total liabilities has changed by -$270.82M (-3.55%)